Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents Growth (1y) (2019 - 2026)
Arcturus Therapeutics Holdings (ARCT) Cash & Equivalents Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 988.88% |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -68.22% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 3.35% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 4.77% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 269.98% |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 17.50% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | -2.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57% |
| Dec 31, 2025 | -21.44% |
| Sep 30, 2025 | -23.96% |
| Jun 30, 2025 | -24.53% |
| Mar 31, 2025 | -24.77% |
| Dec 31, 2024 | 0.65% |
| Sep 30, 2024 | -23.96% |
| Jun 30, 2024 | -19.52% |
| Mar 31, 2024 | -12.06% |
| Dec 31, 2023 | -25.49% |
| Sep 30, 2023 | 31.24% |
| Jun 30, 2023 | 14.10% |
| Mar 31, 2023 | 2.58% |
| Dec 31, 2022 | 5.77% |
| Sep 30, 2022 | -42.57% |
| Jun 30, 2022 | -34.62% |
| Mar 31, 2022 | -31.52% |
| Dec 31, 2021 | -19.96% |
| Sep 30, 2021 | 34.80% |
| Jun 30, 2021 | 218.54% |